[HTML][HTML] Pharmacological treatment of degenerative cervical myelopathy: a critical review of current evidence

JJ Levett, M Georgiopoulos, S Martel, W Al Mugheiry… - Neurospine, 2024 - e-kjs.org
Degenerative cervical myelopathy (DCM) is the leading cause of spinal cord dysfunction in
adults, representing substantial morbidity and significant financial and resource burdens …

A minimum data set—Core outcome set, core data elements, and core measurement set—For degenerative cervical myelopathy research (AO Spine RECODE DCM) …

BM Davies, X Yang, DZ Khan, OD Mowforth… - PLoS …, 2024 - journals.plos.org
Background Degenerative cervical myelopathy (DCM) is a progressive chronic spinal cord
injury estimated to affect 1 in 50 adults. Without standardised guidance, clinical research …

Life expectancy in patients with degenerative cervical myelopathy is currently reduced but can be restored with timely treatment

BM Davies, D Stubbs, CS Gillespie, B Grodzinski… - Acta …, 2023 - Springer
Purpose Degenerative cervical myelopathy is a progressive slow-motion spinal cord injury.
Surgery is the mainstay of treatment. Baseline disability predicts surgical recovery; therefore …

Screening for degenerative cervical myelopathy with the 10-second grip-and-release test using a smartphone and machine learning: A pilot study

T Ibara, R Matsui, T Koyama, E Yamada… - Digital …, 2023 - journals.sagepub.com
Objective Early detection and intervention are essential for the mitigation of degenerative
cervical myelopathy (DCM). However, although several screening methods exist, they are …

Monocentric Retrospective Analysis of Clinical Outcomes, Complications, and Adjacent Segment Disease in 507 Patients Undergoing Anterior Cervical Discectomy …

A Baram, G Capo, M Riva, C Brembilla, E Rosellini… - World Neurosurgery, 2024 - Elsevier
Background Degenerative cervical myelopathy (DCM) is a leading cause of nontraumatic
spinal cord injury. Surgery aims to arrest neurological decline and improve conditions, but …

Validity of a smartphone app to objectively monitor performance outcomes in degenerative cervical myelopathy: an observational study

A Yanez Touzet, T Houhou, Z Rahic, I Laufer… - medRxiv, 2023 - medrxiv.org
Objectives To assess the validity of MoveMed, a battery of performance outcome measures
performed using a mobile phone application, in the measurement of degenerative cervical …

Risk factors of epidural hematoma in patients undergoing spinal surgery: a meta-analysis of 29 cohort studies

M Luo, Q Cao, Z Zhao, Y Shi, Q Yi, J Chen… - … Journal of Surgery, 2023 - journals.lww.com
Objective: The authors conducted this meta-analysis to identify risk factors for spinal epidural
haematoma (SEH) among patients following spinal surgery. Methods: The authors …

Voxel-and tensor-based morphometry with machine learning techniques identifying characteristic brain impairment in patients with cervical spondylotic myelopathy

Y Wang, R Zhao, D Zhu, X Fu, F Sun, Y Cai… - Frontiers in …, 2024 - frontiersin.org
Aim The diagnosis of cervical spondylotic myelopathy (CSM) relies on several methods,
including x-rays, computed tomography, and magnetic resonance imaging (MRI). Although …

Is the type and/or co-existence of degenerative spinal pathology associated with the occurrence of degenerative cervical myelopathy? A single centre retrospective …

BM Davies, A Banerjee, OD Mowforth… - Journal of Clinical …, 2023 - Elsevier
Background Degenerative cervical myelopathy (DCM) arises from spinal degenerative
changes injuring the cervical spinal cord. Most cord compression is incidental, referred to as …

Management of mild degenerative cervical myelopathy and asymptomatic spinal cord compression: an international survey

JFM Brannigan, BM Davies, OD Mowforth, R Yurac… - Spinal cord, 2024 - nature.com
Study design Cross-sectional survey. Objective Currently there is limited evidence and
guidance on the management of mild degenerative cervical myelopathy (DCM) and …